Effects of personalized vitamin D3 on inflammation in colorectal cancer patients: a randomized trial
In CRC patients with low vitamin D status, VIDS reduces serum IL-6, a pro-inflammatory biomarker associated with poor prognosis. Further research should explore a potential supportive therapeutic role of VIDS in managing inflammation and improving CRC outcomes. [Words: 200].
Authors
- David Czock (ORCID: https://orcid.org/0000-0003-1217-5134)
- Marija Slavić
- Kira Trares (ORCID: https://orcid.org/0000-0002-1775-3231)
- Tomislav Vlaški (ORCID: https://orcid.org/0000-0002-1128-1288)
- Bettine Bilsing
- Tafirenyika Gwenzi (ORCID: https://orcid.org/0000-0001-5683-6315)
- Heléne Fischer (ORCID: https://orcid.org/0000-0002-5583-2088)
- Reiner Caspari
- Ben Schöttker
- Edelmann Dominic
- Cristina-Maria Fernandes-Almeida
- Alexander N. R. Weber
- Hermann Brenner
- Sha Sha
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- National Center for Tumor Diseases (DE)
- Research Institute for Work, Technology and Culture (DE)
- Klinik Niederrhein (DE)
- Helmholtz Centre for Infection Research (DE)
- University Children's Hospital Tübingen (DE)
- Klinik Rosenberg (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1038/s41416-025-03333-6
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsches Krebsforschungszentrum
- World Cancer Research Fund International
- Wereld Kanker Onderzoek Fonds
- World Cancer Research Fund